8 results
management diagnosis algorithm doac oncology adultonset anterior anticoagulation chemotherapy clinical disease eoe eosinophilic gastroenteritis gastroenterology hemophagocytic hlh inducers inhibitors interactions
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... cytochrome p450 CYP3A4 ... substrates to CYP3A4 ... Chemotherapy #Oncology #Hematology ... Interactions #Table #Pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... VTE #Malignancy #Cancer ... Anticoagulation #Management #Hematology
►
 Eosinophilic Gastroenteritis: Treatment Options Based on Severity of the Disease Mild: • Trial of PPI • Trial
Gastroenteritis: Treatment ... strictures Severe + Concern ... for HES: • Hematology ... consult for evaluation ... Gastroenteritis #Treatment
Anterior Non-necrotizing Scleritis - Slit Lamp Ocular Examination This 57 yo WM reported to clinic complaining of
patient was sent to rheumatology ... systemic workup and treatment ... Bennett & Bloom Eye Center ... #physicalexam #rheumatology ... #SlitLamp
►
 Adult-Onset Still's Disease Clinical triad: Fever, Arthralgia/arthritis, Skin rash ± odynophagia + Biological inflammation: Increased neutrophils, Hyperferritinemia, decreased
hemopathies, solid cancers ... hepatitis • Pulmonary ... diagnosis #management #treatment ... #rheumatology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
B-LNH), solid cancers ... Unknown cause Treatment ... inhibitors under evaluation ... diagnosis #management #treatment ... #summary #rheumatology
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology
Myelodysplastic syndromes current treatment algorithm 2018. From Blood Cancer Journal, Published 24 May 2018 Myelodysplastic syndromes (MDS) are
syndromes current treatment ... risk of clonal evolution ... influence outcomes and treatment ... cardiovascular or pulmonary ... #algorithm #hematology
No results found for "Evolution pulmonary treatment slitlamp pharmacology cancer rheumatology cyp3a4 hematology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Evolution #pulmonary #treatment #slitlamp #pharmacology #cancer #rheumatology #cyp3a4 #hematology